Remove 2016 Remove Clinical Trials Remove Events Remove History
article thumbnail

Court Dismisses Case Demanding DEA to Move Expeditiously to License Cannabis Cultivators

NORML

The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials. Since 1968, the agency has only licensed the University of Mississippi to engage in the growing of cannabis for FDA-approved clinical research.

DEA 103
article thumbnail

Cannabis laws in Japan: Is weed legal?

The Cannigma

However, the country has a history of cannabis art dating back millenia , and scholars believe that the plant was used for centuries as a textile and for use in traditional Shinto ceremonies. Since 2016, the country has permitted the sale of CBD and some Japanese companies produce cannabidiol products as well. But in modern times?

Law 137
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Dalrada Corporation Expands Presence in Top Three Growth Industries: Clean Energy, Healthcare, Technology (IT)

Cannabis Law Report

This calendar year marks a synchronous period in Dalrada’s history when its impactful innovations and solutions of all its subsidiaries expanded market presence into the top three largest growing industries : clean energy, healthcare, and technology. In its history, IHG has graduated nearly 8,000 students.

article thumbnail

Jones Day: The life sciences regulatory regime in Australia

Cannabis Law Report

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.

article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Legalisation occurred in Australia in 2016. It also has an extensive and diverse history of medicinal use. 2016 ; Sznitman et al. Before 2016, Australian law considered cannabis an illegal drug.

article thumbnail

NO BRAINER: CBD AND THC FOR HEAD INJURIES

Green Relief

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. Thus far, however, there have been no FDA -sanctioned clinical trials to ascertain the efficacy of whole plant, CBD -rich cannabis oil for traumatic brain injury.

THC 64